These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1081913)
1. A comparison of the effects of metabolic inhibitors upon direct and antibody-dependent lymphocyte mediated cytotoxicity. Strom TB; Garovoy MR; Bear RA; Gribik M; Carpenter CB Cell Immunol; 1975 Dec; 20(2):247-56. PubMed ID: 1081913 [No Abstract] [Full Text] [Related]
3. Regulation of amino acid uptake in lymphocytes stimulated by mitogens. I. Increase in AIB transport dependent on cell metabolism. van den Berg KJ; Betel I Exp Cell Res; 1974 Mar; 84(1):412-8. PubMed ID: 4817729 [No Abstract] [Full Text] [Related]
10. Comparative study of antibody-dependent and direct lymphocyte-mediated cytotoxicity in vitro after alloimmunization in the human. II. Chemical inhibitors. Dickmeiss E Scand J Immunol; 1974; 3(6):817-21. PubMed ID: 4218363 [No Abstract] [Full Text] [Related]
11. Differential effects of ouabain on human cell-mediated cytotoxicity. I. Inhibition of mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity against chicken red cell targets. Lawrence EC; Muchmore AV; Dooley NJ; Blaese RM Cell Immunol; 1979 Aug; 46(1):100-9. PubMed ID: 314844 [No Abstract] [Full Text] [Related]
12. Enhancing antibody: in vitro studies on mechanism of action upon the sensitization and effector arc. Phillips SM; Strom TB; Corson JM; Carpenter CB; Merrill JP Transplant Proc; 1973 Mar; 5(1):577-80. PubMed ID: 4266670 [No Abstract] [Full Text] [Related]
13. Antibody-dependent, eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: effect of metabolic inhibitors and other agents which alter cell function. David JR; Butterworth AE; Remold HG; David PH; Houba V; Sturrock RF J Immunol; 1977 Jun; 118(6):2221-9. PubMed ID: 193993 [TBL] [Abstract][Full Text] [Related]
14. Suppression of in vivo and in vitro alloimmunity by prostaglandins. Strom TB; Carpenter CB; Cragoe EJ; Norris S; Devlin R; Perper RJ Transplant Proc; 1977 Mar; 9(1):1075-9. PubMed ID: 325735 [No Abstract] [Full Text] [Related]
15. Graft enhancement and antiidiotypic antibody. Lymphocytes from long-term rat renal allograft recipients have normal responsiveness in vitro. Fitch FW; Weiss A; McKearn TJ; Stuart FP Transplant Proc; 1978 Jun; 10(2):367-72. PubMed ID: 79259 [No Abstract] [Full Text] [Related]
16. Cellular and humoral immunity after allogeneic transplantation in the rat. II. Comparison of a 51Cr release assay and modified microcytotoxicity assay for detection of cellular immunity and blocking serum factors. Biesecker JL; Fitch FW; Rowley DA; Scollard D; Stuart FP Transplantation; 1973 Nov; 16(5):421-31. PubMed ID: 4584952 [No Abstract] [Full Text] [Related]
18. Rejection and enhancement in an in vitro model of alloimmunity. Strom TB; Carpenter CB; Phillips SM; Garovoy MR; Merrill JP Transplantation; 1973 Aug; 16(2):103-9. PubMed ID: 4581397 [No Abstract] [Full Text] [Related]
19. Cellular and humoral immunity after allogeneic transplantation in the rat. 3. The effect of passive antibody on cellular and humoral immunity after allogeneic renal transplantation. Biesecker JL; Fitch FW; Rowley DA; Stuart FP Transplantation; 1973 Nov; 16(5):432-40. PubMed ID: 4584953 [No Abstract] [Full Text] [Related]
20. The thymic suppre-sor cell. II. Metabolic requirements of suppressor activity. Ha TY; Waksman BH; Treffers HP Immunol Commun; 1974; 3(4):351-9. PubMed ID: 4142785 [No Abstract] [Full Text] [Related] [Next] [New Search]